Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP59639.RAHmrY_WagYMomYrWkUWTR-0-_RVU7FPPQk1dl_EEPV6A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP59639.RAHmrY_WagYMomYrWkUWTR-0-_RVU7FPPQk1dl_EEPV6A130_assertion type Assertion NP59639.RAHmrY_WagYMomYrWkUWTR-0-_RVU7FPPQk1dl_EEPV6A130_head.
- NP59639.RAHmrY_WagYMomYrWkUWTR-0-_RVU7FPPQk1dl_EEPV6A130_assertion description "[Our data do not show a survival advantage for type 2 diabetes hemodialysis patients receiving RAS inhibiting therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP59639.RAHmrY_WagYMomYrWkUWTR-0-_RVU7FPPQk1dl_EEPV6A130_provenance.
- NP59639.RAHmrY_WagYMomYrWkUWTR-0-_RVU7FPPQk1dl_EEPV6A130_assertion evidence source_evidence_literature NP59639.RAHmrY_WagYMomYrWkUWTR-0-_RVU7FPPQk1dl_EEPV6A130_provenance.
- NP59639.RAHmrY_WagYMomYrWkUWTR-0-_RVU7FPPQk1dl_EEPV6A130_assertion SIO_000772 15946912 NP59639.RAHmrY_WagYMomYrWkUWTR-0-_RVU7FPPQk1dl_EEPV6A130_provenance.
- NP59639.RAHmrY_WagYMomYrWkUWTR-0-_RVU7FPPQk1dl_EEPV6A130_assertion wasDerivedFrom gad-20150221 NP59639.RAHmrY_WagYMomYrWkUWTR-0-_RVU7FPPQk1dl_EEPV6A130_provenance.
- NP59639.RAHmrY_WagYMomYrWkUWTR-0-_RVU7FPPQk1dl_EEPV6A130_assertion wasGeneratedBy ECO_0000203 NP59639.RAHmrY_WagYMomYrWkUWTR-0-_RVU7FPPQk1dl_EEPV6A130_provenance.